Haemonetics is THE Blood Management Company. Our comprehensive portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood management continuum. Collectively they help improve patient care, ensure patient safety, and reduce costs for blood and plasma collectors, hospitals, and patients around the world. Our Mission We believe that through proper blood management, our products and services can help our commercial plasma and blood center customers optimize their collection processes. We seek to help ensure a continual supply of high-quality plasma for biopharmaceuticals and blood components for therapeutic use at optimal costs, along with better blood management processes. Working with our hospital customers, we seek to prevent a blood transfusion to the patient who doesn’t need one, or, if a transfusion is necessary, to ensure the transfusion of the right blood product, at the right time, in the right dose to the patient who does.
Show more
Type
Public
HQ
Braintree, US
Founded
1971
Size (employees)
3,107 (est)
Haemonetics Corporation was founded in 1971 and is headquartered in Braintree, US
Report incorrect company information

Haemonetics Corporation Office Locations

Haemonetics Corporation has offices in Beirut, South Seberang Perai, Auckland, Braintree and in 10 other locations
Braintree, US (HQ)
400 Wood Rd
Macquarie Park, AU
Level 2, Everglade Campus 82 Waterloo Rd
Edmonton, CA
500 TD Tower 10025 102A Ave NW
Vancouver, CA
1099 W 8th Ave
Bengaluru, IN
104 EPIP Zone Whitefield Rd
Gingins, CH
Rlle du Ctre
Show all (14)
Report incorrect company information

Haemonetics Corporation Financials and Metrics

Haemonetics Corporation Financials

Haemonetics Corporation's revenue was reported to be $903.92 m in FY, 2018
USD

Revenue (FY, 2018)

903.9 m

Gross profit (FY, 2018)

411.9 m

Gross profit margin (FY, 2018), %

45.6%

Net income (FY, 2018)

45.6 m

EBIT (FY, 2018)

56.2 m

Market capitalization (22-Jun-2018)

4.9 b

Closing share price (22-Jun-2018)

93

Cash (31-Mar-2018)

180.2 m
Haemonetics Corporation's current market capitalization is $4.9 b.
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

938.5 m910.4 m908.8 m903.9 m

Revenue growth, %

(3%)0%

Cost of goods sold

470.1 m476 m502.9 m492 m

Gross profit

468.4 m434.4 m405.9 m411.9 m
Quarterly
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q2, 2016Q1, 2016Q3, 2017Q1, 2017

Revenue

213.4 m219.7 m233.4 m220.3 m210 m227.8 m211 m

Cost of goods sold

110.9 m114.4 m124.5 m116 m118.9 m126.8 m119.3 m

Gross profit

102.5 m105.3 m108.9 m104.2 m91.1 m101.1 m91.7 m

Gross profit Margin, %

48%48%47%47%43%44%43%
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

192.5 m160.7 m115.1 m139.6 m180.2 m

Accounts Receivable

319.2 m

Inventories

54.1 m40.1 m28.8 m176.9 m160.8 m

Current Assets

623 m570.3 m488.1 m510 m521.2 m
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q2, 2016Q1, 2016Q3, 2017Q1, 2017

Cash

159.1 m177.8 m139.9 m130 m125.2 m112.2 m100.2 m105.2 m138.9 m118.2 m129.6 m171.7 m

Inventories

205.3 m209.3 m207.5 m209.4 m212.5 m211.1 m207.6 m203.9 m194.5 m189.4 m188.5 m173.9 m

Current Assets

592.1 m603.3 m569.3 m557 m549.8 m508.4 m500.7 m501.4 m512.4 m489.6 m496.6 m528.1 m

PP&E

328.2 m332.8 m339.8 m339.7 m336 m322 m
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

35.1 m16.9 m(55.6 m)(26.3 m)45.6 m

Depreciation and Amortization

81.7 m86.1 m89.9 m89.7 m89.2 m

Inventories

(13 m)(17 m)11.9 m(1.6 m)14.4 m

Accounts Payable

477 k2 m(30.2 m)21.1 m41.4 m
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q2, 2016Q1, 2016Q3, 2017Q1, 2017

Net Income

8.7 m25 m(3.6 m)3.8 m19.8 m(267 k)12.6 m(46.8 m)9.5 m(10.3 m)24.9 m20.1 m

Depreciation and Amortization

38.3 m59.1 m20.5 m41.6 m63.9 m22.3 m45 m67.7 m45.3 m22.5 m67.5 m21.8 m

Inventories

(19.3 m)(24.6 m)(9.6 m)(13.2 m)(17.9 m)(718 k)2.5 m6.3 m(12.7 m)(3.7 m)(14 m)1.4 m

Accounts Payable

(5.3 m)(25.2 m)(27.1 m)(40 m)6.2 m8.3 m20.3 m(11.9 m)
USDY, 2018

Revenue/Employee

290.9 k

Financial Leverage

1.6 x
Show all financial metrics

Haemonetics Corporation Operating Metrics

FY, 2016

Facilities

8
Show all operating metrics

Haemonetics Corporation Revenue Breakdown

Embed Graph

Haemonetics Corporation revenue breakdown by business segment: 100.0% from North America Plasma

Haemonetics Corporation revenue breakdown by geographic segment: 58.8% from All Other, 27.9% from EMEA and 13.4% from Japan

Report incorrect company information

Haemonetics Corporation Online and Social Media Presence

Embed Graph
Report incorrect company information

Haemonetics Corporation News and Updates

“Global Apheresis Market” Top Key Companies Kidde-Fenwal Inc., Haemonetics Corporation, Arteriocyte Medical Systems, Inc. – Industry Trends and Forecast to 2024

Global Apheresis Market Product (Apheresis Devices, Apheresis Disposables), Disease (Hematology, Autoimmune disease, Cardiovascular diseases, Neurology, Metabolic Disorders, Renal diseases), Procedure (Plasmapheresis, LDL-apheresis, Plateletpheresis, Photopheresis, Leukapheresis, Erythrocytapheresi…

Global Apheresis Market 2018 Key Players: Haemonetics Corporation, Fresenius Medical Care, Terumo BCT, Inc, Asahi Kasei Medical, Kawasumi Laboratories, Cerus Corporation,.

WiseGuyReports.com adds “Apheresis Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2022”reports to its database. Posted via Industry Today. Follow us on Twitter @IndustryToday

Plasmapheresis Machines 2017 Global Key Players –Haemonetics Corporation, Fresenius Medical Care, Nikkiso, Terumo BCT, Nigale Biomedical Inc Market Analysis And Forecast To 2022

Wiseguyreports.Com Adds “Plasmapheresis Machines – Global Market Demand, Growth, Opportunities, Manufacturers, Analysis of Top Key Players and Forecast to 2022” To Its Research Database. Posted via Industry Today. Follow us on Twitter @IndustryToday
Report incorrect company information